A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2.
Zvonimir BosnicFrantišek BabičViera AnderkováLjiljana Trtica MajnaricThomas WittlingerLjiljana Trtica MajnarićPublished in: International journal of environmental research and public health (2023)
The study has revealed limitations in using classical approaches in determining the diagnostic and prognostic utility of the cytokine IL-37 in patients with T2D and lain a foundation for new methodology approaches.
Keyphrases